Two Sigma Investments, LP Enanta Pharmaceuticals Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 191,257 shares of ENTA stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

191,257

Previous 184,557 3.63%

Holding current value

$1.21 Million

Previous $2.39 Million 17.13%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $16.54 $67,335 - $110,818	6,700 Added 3.63%	191,257 $1.98 Million
Q2 2024 Aug 14, 2024	SELL	$11.43 - $17.02 $831,555 - $1.24 Million	-72,752 Reduced 28.27%	184,557 $2.39 Million
Q1 2024 May 15, 2024	SELL	$10.08 - $17.46 $755,223 - $1.31 Million	-74,923 Reduced 22.55%	257,309 $4.49 Million
Q4 2023 Feb 14, 2024	BUY	$8.18 - $10.78 $983,751 - $1.3 Million	120,263 Added 56.74%	332,232 $3.13 Million
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $2.02 Million - $4.04 Million	182,346 Added 615.56%	211,969 $2.37 Million
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $612,603 - $1.18 Million	29,623 New	29,623 $633,000
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $730,679 - $962,949	17,922 Added 126.28%	32,114 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $29,022 - $42,833	601 Added 4.42%	14,192 $736,000
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $518,224 - $1.05 Million	13,591 New	13,591 $642,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $4.64 Million - $6.13 Million	-82,682 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $1.08 Million - $1.74 Million	17,904 Added 27.64%	82,682 $6.18 Million
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $36,876 - $52,726	-899 Reduced 1.37%	64,778 $3.68 Million
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $55,443 - $67,290	1,267 Added 1.97%	65,677 $2.89 Million
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $34,561 - $45,553	-829 Reduced 1.27%	64,410 $3.18 Million
Q4 2020 Feb 16, 2021	BUY	$41.16 - $47.47 $752,610 - $867,988	18,285 Added 38.94%	65,239 $2.75 Million
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $858,267 - $1.06 Million	-19,794 Reduced 29.65%	46,954 $2.15 Million
Q2 2020 Aug 14, 2020	SELL	$46.37 - $57.58 $1.67 Million - $2.07 Million	-35,986 Reduced 35.03%	66,748 $3.35 Million
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $1.29 Million - $1.99 Million	-32,021 Reduced 23.76%	102,734 $5.28 Million
Q4 2019 Feb 14, 2020	BUY	$57.95 - $66.61 $3.84 Million - $4.41 Million	66,198 Added 96.56%	134,755 $8.33 Million
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $571,420 - $838,584	9,511 Added 16.11%	68,557 $4.12 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $2.53 Million - $3.03 Million	31,150 Added 111.66%	59,046 $4.98 Million
Q1 2019 May 15, 2019	SELL	$69.08 - $105.66 $2.28 Million - $3.48 Million	-32,971 Reduced 54.17%	27,896 $2.67 Million
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $2.44 Million - $3.16 Million	37,352 Added 158.84%	60,867 $4.31 Million
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $2.01 Million - $2.97 Million	23,515 New	23,515 $2.01 Million
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $4.44 Million - $6.54 Million	-54,295 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$57.91 - $92.15 $269,860 - $429,419	-4,660 Reduced 7.9%	54,295 $4.39 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $2.05 Million - $2.67 Million	45,002 Added 322.53%	58,955 $3.46 Million
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $528,958 - $653,000	13,953	13,953 $653,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $131M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Enanta Pharmaceuticals Inc Transaction History